Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00961051 · ClinicalTrials.gov registry record · Phase 3
Evaluation of an Investigational Multi-Purpose Solution (MPS)
A Phase 3 study, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- Phase 3
- Development phase
- 270
- Enrollment target
NCT00961051: Completed Phase 3 study, sponsored by Abbott Medical Optics.
NCT00961051 is a Phase 3 study that has completed, run by Abbott Medical Optics. The registered enrollment target is 270 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00961051, a Phase 3 study, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 270 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of an investigational multi-purpose contact lens solution.
Primary Outcome
Lens cleanliness was assessed by total light reflectance, which is a computerized quantitative assessment conducted in a laboratory. The amount of light that scattered off the lens surface in a light field and was assessed using a light reflectance score that ranged from 0 (maximum lens cleanliness; clean/clear) to100 (minimum lens cleanliness; dirty/opaque).
Interventions
- DEVICE Investigational MPS
- DEVICE Opti-Free
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-11 |
| Phase | Phase 3 |
What the finished NCT00961051 record still lists
NCT00961051 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which Investigational MPS is the first listed.
NCT00961051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00961051 about?
NCT00961051 is a clinical study titled "Evaluation of an Investigational Multi-Purpose Solution (MPS)". The purpose of this study is to evaluate the safety and effectiveness of an investigational multi-purpose contact lens solution.
What is the current status of trial NCT00961051?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 270 participants. The study started on 2009-02. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00961051?
The interventions under investigation include: Investigational MPS (DEVICE), Opti-Free (DEVICE).
Who is sponsoring clinical trial NCT00961051?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00961051's enrollment target sits among peer trials
270 1217th of 2000 higher than 781 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia